Telix Pharmaceuticals TLX
NASDAQ TLX
$9.63 +0.21 (+2.23%)
At close: Nov 6, 2026 · 4:00 PM EST

Telix Pharmaceuticals (TLX) Other Accumulated Expenses (2024 - 2025)

Updated

Telix Pharmaceuticals (TLX) posted Other Accumulated Expenses of $72.45 million for the quarter ended Dec 31, 2025, down 16.0% from $86.25 million a year earlier.

Analysis

Telix Pharmaceuticals (TLX) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

  • In prior years, Telix Pharmaceuticals' Other Accumulated Expenses was $86.25 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Telix Pharmaceuticals 3.26 Bn 2.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 91.33 Mn
Dec 31, 2024 160.44 Mn
API Access

Telix Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TLX&period=max&api_key=YOUR_API_KEY